Indiana Administrative Code
Title 71 - INDIANA HORSE RACING COMMISSION
Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH
Rule 1 - Rule1Equine Health; Medication Rules
Section 1-2.5 - Thyroxine restricted
Current through March 20, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 2.5.
(a) Thyroid supplementation is prohibited. Trainers shall not have thyroxine, any other thyroid hormone, thyroid hormone analog, or thyroid supplements on the premise of a facility under the jurisdiction of the commission, nor shall they administer such supplements unless both of the following conditions have been met:
A T3 or T4 test without stimulation of the thyroid is insufficient to diagnose hypothyroidism.
(b) If approved by the equine medical director, the horse shall be treated with only Federal Drug Administration approved medications for hypothyroidism prescribed by a veterinarian. Possession of any thyroid supplements that are not pursuant to a veterinary prescription is prohibited.
(c) The prescription for thyroxine or any other thyroid hormone or thyroid hormone analog administration shall not exceed ninety (90) calendar days, after which the prescription must be reauthorized by the equine medical director under either of the following circumstances:
(d) A horse administered thyroxine or any other thyroid hormone or thyroid hormone analog, pursuant to this section, is ineligible to start in a race for thirty (30) calendar days after the last administration.
(e) If a horse is currently being administered a thyroid supplement, administration of the supplement shall be discontinued and a TRH test conducted after a thirty (30) day washout period before the horse is eligible to race.
(f) Possession of thyroxine or any other thyroid hormone or thyroid hormone analog on the premise of a facility under the jurisdiction of the commission is prohibited without a prescription obtained in compliance with this section.
(g) In the absence of the equine medical director, or, if there is no appointed equine medical director, the commission or executive director may designate an alternate regulatory veterinary official for this section.